TDC
TRPX

Thompson Davis & Co’s Therapix Biosciences Ltd. TRPX Stock Holding History

Thompson Davis & Co’s Portfolio TRPX Stock Details TRPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$120K Buy
+28,634
New +$111K 0.26% 90

Other funds holding TRPX

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return

Thompson Davis & Co's TRPX Position: Q3 2018 in Review

Thompson Davis & Co opened a new position in Therapix Biosciences Ltd. (TRPX) in Q3 2018: 28,634 shares worth $120K. The stake represents 0.26% of the portfolio and ranks #90 among its holdings.

6 funds tracked by Wall St. Rank hold TRPX as of Q3 2018.

  • Thompson Davis & Co held 28,634 shares of Therapix Biosciences Ltd. worth $120K as of Q3 2018.
  • Therapix Biosciences Ltd. was a new Thompson Davis & Co position in Q3 2018.
  • Therapix Biosciences Ltd. made up 0.26% of Thompson Davis & Co's portfolio in Q3 2018, its #90 holding.
  • 6 funds tracked by Wall St. Rank held Therapix Biosciences Ltd. as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.